The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Off-label Use of Antineoplastic Drugs in Children
Author(s): 
Pages: 484-486
Year: Issue:  4
Journal: Evaluation and Analysis of Drug-Use in Hospital of China

Keyword:  ChildrenOff-label drug useAntineoplastic drugAnalysis of drug use;
Abstract: OBJECTIVE: To investigate the off-label use of antineoplastic drugs in Zhengzhou Children’s Hospital( hereinafter referred to as"our hospital") in order to promote clinical rational use of drug. METHODS: The medical records of the patients who had been treated with antineoplastic drugs discharged from our hospital during JulyDecember period of 2013 were analyzed with regard to off-label drug use. RESULTS: A total of 595 medical records containing 6 497 antineoplastic medication orders were reviewed. The off-label drug use was noted in 429 medical records,accounting for 72. 10% and there were a total of 1 606 off-label medication orders,accounting for 24. 72%.The drugs ranked in descending order in the incidence of off-label use were alkylating agents( 79. 56%),antitumor antibiotics( 62. 26%) and plant-derived anticancer drugs( 31. 38%). The top three types of off-label use were offlabel single dose( 47. 38%),off-label indications( 27. 11%) and off-label route of administration( 17. 56%). The top three antineoplastic ranked by number of off-label medical orders were Calcium Folinate-SF injections( 551),etoposide injections( 482) and cyclophosphamide injections( 373). CONCLUSIONS: The off-label use ofantineoplastic drugs is common in our hospital,and some off-label use is evidence-based,is evidence-based learning,however,it is important to tighten monitoring on the use of antineoplastic drugs and standardize their use so as to safe and rational ensure medication safety among children.
Related Articles
loading...